U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07343245) titled 'A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs' on Dec. 22, 2025.
Brief Summary: Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs
Study Start Date: Dec. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Adult
Intervention:
DRUG: DW4421
QD
DRUG: DW4421-N1
BID
DRUG: DW4421-N2
BID
DRUG: DW4421-N3
QD
Recruitment Status: RECRUITING
Sponsor: Daewon Pharmaceutical Co., Ltd.
Disclaimer: Curated by HT Syndication....